首页> 外国专利> (5)-Methyl-isoxazole-(3)-carboxylate salts - hypolipaemics antilipolytics, prepd. by reacting substd. theophylline derivs. with (5)-methyl-isoxazole-(3)-carboxylic acid

(5)-Methyl-isoxazole-(3)-carboxylate salts - hypolipaemics antilipolytics, prepd. by reacting substd. theophylline derivs. with (5)-methyl-isoxazole-(3)-carboxylic acid

机译:(5)-甲基-异恶唑-(3)-羧酸盐-降血脂的抗脂解药,制备。通过反应茶碱衍生。与(5)-甲基-异恶唑-(3)-羧酸

摘要

New 5-metyl-isoxazole-3-carboxylates are salts of formula (I). In this formula R1 and R2 are H; 1-4C alkyl; hydroxyalkyl; alkoxyalkyl; or cycloalkyl. (I) have lipolysis-inhibiting and triglyceride-lowering activity. They can be used therapeutically for the treatment of hyperlipidaemias. Dosage as 1-10 mg one or more times per day. Details of biological tests showing the effects of (I; R1=Me, R2=CH2CH2OH) on lipid metabolism in rats are given in the specification. Thus, serum triglycerides are significantly lowered by doeses up to 5 mg/kg. The effect on serum cholesterol is only short-term: 300 mg/kg p.o. only lowers serum cholesterol for 3 hrs. after administration. Blood sugar levels are significantly lowered by does of 200 and 300 mg/kg.
机译:新的5-甲基-异恶唑-3-羧酸盐是式(I)的盐。在该式中,R1和R2为H; 1-4C烷基;羟烷基;烷氧基烷基;或环烷基。 (I)具有抑制脂肪分解和降低甘油三酸酯的活性。它们可以治疗性地用于治疗高脂血症。剂量为1-10毫克,每天一次或多次。说明书中给出了生物测试的详细信息,其中显示了(I; R1 = Me,R2 = CH2CH2OH)对大鼠脂质代谢的影响。因此,剂量最高可降低5 mg / kg的血清甘油三酸酯。对血清胆固醇的影响只是短期的:300 mg / kgp.o。仅降低3小时的血清胆固醇。管理后。血糖水平显着降低了200和300 mg / kg。

著录项

  • 公开/公告号NL7613837A

    专利类型

  • 公开/公告日1978-06-15

    原文格式PDF

  • 申请/专利号NL19760013837

  • 发明设计人

    申请日1976-12-13

  • 分类号C07D473/08;A61K31/52;

  • 国家 NL

  • 入库时间 2022-08-22 22:47:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号